Skip to main content

Aravind Asokan

Professor in Surgery
Surgery, Surgical Sciences

Overview


Synthetic Virology & Gene Therapy

Current Appointments & Affiliations


Professor in Surgery · 2019 - Present Surgery, Surgical Sciences, Surgery
Director of Gene Therapy · 2018 - Present Surgery, Surgical Sciences, Surgery
Professor of Molecular Genetics and Microbiology · 2019 - Present Molecular Genetics and Microbiology, Basic Science Departments
Professor of Biomedical Engineering · 2019 - Present Biomedical Engineering, Pratt School of Engineering
Affiliate of the Duke Regeneration Center · 2021 - Present Duke Regeneration Center, Basic Science Departments

In the News


Published December 11, 2025
Duke Researchers Selected to National Academy of Inventors
Published September 15, 2023
Duke Companies and Faculty Share Ideas with Investors at Triangle Venture Day
Published December 13, 2022
Gene Therapy for Heart Attacks in Mice Just Got More Precise

View All News

Recent Publications


Complete neutralizing antibody evasion by serodivergent non-mammalian AAVs enables gene therapy redosing.

Journal Article Cell Rep Med · December 16, 2025 The use of adeno-associated virus (AAV) as a gene therapy vector is significantly limited by pre-existing immunity. The high seroprevalence and broad antigenic cross-reactivity of primate-derived AAVs restrict patient eligibility and preclude therapeutic r ... Full text Link to item Cite

Efficient kidney gene transfer and proximal tubule transduction using self-complementary AAV.cc47 vectors.

Journal Article Mol Ther Methods Clin Dev · December 11, 2025 Gene delivery to critical cell types within the kidney can enable preclinical evaluation of gene therapies for kidney disease. The novel adeno-associated virus AAV.cc47 was discovered after sequential evolution in mice, pigs, and macaques and improved tran ... Full text Link to item Cite
View All Publications

Recent Grants


Interdisciplinary Research Training Program in AIDS

Inst. Training Prgm or CMEAdvisor · Awarded by National Institutes of Health · 2010 - 2030

Kidney targeted AAV for gene therapy

ResearchPrincipal Investigator · Awarded by Vanderbilt University Medical Center · 2025 - 2030

Immunomodulation in AAV gene therapy

ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2029

View All Grants

Education, Training & Certifications


University of North Carolina, Chapel Hill · 2004 Ph.D.